Quantifying mRNA and microrna with qPCR in cervical carcinogenesis: A validation of reference genes to ensure accurate data

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Da Conceicao Gomes Leitao, Maria ^a   Coimbra, Eliane Campos ^a   De Cássia Pereira De Lima, Rita ^a   De Lima Guimarães, Mariléa ^a   De Andrade Heráclio, Sandra ^a   Da Costa Silva Neto, Jacinto ^a   De Freitas, Antonio Carlos ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ACTB GENE; ANALYSIS OF VARIANCE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLPOSCOPY; CONTROLLED STUDY; EEF1A1 GENE; FEMALE; GAPDH GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC STABILITY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RPLPO GENE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VALIDATION PROCESS; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REPRODUCIBILITY; RNA STABILITY; UTERINE CERVIX; UTERINE CERVIX TUMOR;

CELL TRANSFORMATION, NEOPLASTIC; CERVIX UTERI; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA STABILITY; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 84909606612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111021     Document Type: Article

References (52)

1. Parkin DM (2006) The global health burden of infection-associated cancers in the year. Int J Cancer 118:3030-3044.
2. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350.
3. Stoler MH, Schiffman M (2001) Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUSLSIL Triage Study. JAMA 285:1500-1505.
4. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, et al. (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119:1095-1101.
5. Schiffman M, Wentzensen N (2010) From human papillomavirus to cervical cancer. Obstet Gynecol 116:177-185.
6. Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, et al. (2012) Performance of p16/Ki-67 Immunostaining to Detect Cervical Cancer Precursors in a Colposcopy Referral Population. Clin Cancer Res 18:4154-4162.
7. Pinto AP, Crum CP, Hirsch MS (2010) Molecular markers of early cervical neoplasia. Diagn Histopathol 16:445-454.
8. Martin CM, Astbury K, McEvoy L, O'Toole S, Sheils O, et al. (2009) Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy. Methods Mol Biol 511:333-359.
9. Freitas AC, Coimbra EC, Leitão MD (2014) Molecular targets of HPV oncoproteins: Potential biomarkers for cervical carcinogenesis. Biochim Biophys Acta 1845:91-103.
10. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611-622.
11. Bustin SA, Beaulieu JF, Huggett J, Jaggi R, Kibenge FS, et al. (2010) MIQE précis: Practical implementation of minimum standard guidelines for fluorescencebased quantitative real-time PCR experiments. BMC Mol Biol 11:74.
12. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 [RESEARCH0034].
13. Eisenberg E, Levanon EY (2003) Human housekeeping genes are compact. Trends Genet 19:362-365.
14. Saviozzi S, Cordero F, Lo Iacono M, Novello S, Scagliotti GV et al. (2006) Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer. BMC Cancer 26, 6:1-10.
15. Pereira PM, Marques JP, Soares AR, Carreto L, Santos M A S (2010) MicroRNA expression variability in human cervical tissues. PLoS One 5:e11780.
16. Schaefer A, Jung M, Miller K, Lein M, Kristiansen G, et al. (2010) Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med 42:749-758.
17. Liao J, Yu L, Mei Y, Guarnera M, Shen J, et al. (2010) Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer 9:198.
18. Zhang SD, Gant TW (2005) Effect of pooling samples on the efficiency of comparative studies using microarrays. Bioinformatics 21:4378-4383.
19. Shen Y, Li Y, Ye F, Wang F, Lu W, et al. (2010) Identification of suitable reference genes for measurement of gene expression in human cervical tissues. Anal Biochem 405:224-229.
20. Shen Y, Li Y, Wang F, Wan X, Lu W, et al. (2011) Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Exp Mol Med 43:358-366.
21. Dheda K, Huggett JF, Chang JS, Kim LU, Bustin SA, et al. (2005) The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem 344:141-143.
22. Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14:844-852.
23. Chao A, Wang TH, Lee YS, Hsueh S, Chao AS, et al. (2006) Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 119:91-98.
24. Cheng Y, Ji R, Yue J, Yang J, Liu X, et al. (2007) MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 170:1831-1840.
25. Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, et al. (2010) A microRNA expression signature for cervical cancer prognosis. Cancer Res 70:1441-1448.
26. Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, et al. (2011) Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One 6:e28423.
27. Soto-Reyes E, González-Barrios R, Cisneros-Soberanis F, Herrera-Goepfert R, Pérez V, et al. (2012) Disruption of CTCF at the miR-125b1 locus in gynecological cancers. BMC Cancer 12:40.
28. Chagas BS, Batista MV, Guimarães V, Balbino VQ, Crovella S, et al. (2011) New variants of E6 and E7 oncogenes of human papillomavirus type 31 identified in Northeastern Brazil, Gynecol. Oncol 123:284-288.
29. Hagemann T, Bozanovic T, Hooper S, Ljubic A, Slettenaar VI, et al. (2007) Molecular profiling of cervical cancer progression. Br J Cancer 96:321-328.
30. Sheng J, Zhang WY (2010) Identification of biomarkers for cervical cancer in peripheral blood lymphocytes using oligonucleotide microarrays. Chin Med J 123:1000-1005.
31. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, et al. (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10:R64.
32. Cheah PL, Looi LM, Teoh KH, Mun KS, Nazarina AR (2012) p16 (INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies. Asian Pac J Cancer Prev 13:469-472.
33. INK4a immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping. J Gynecol Oncol 24:215-221.
34. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, et al. (2008) Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 14:2535-2542.
35. Melar-New M, Laimins LA (2010) Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol 84:5212-5221.
36. Rajkumar T, Sabitha K, Vijayalakshmi N, Sundersingh S, Bose MV, et al. (2011) Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer 11:80.
37. Rao Q, Shen Q, Zhou H, Peng Y, Li J, et al. (2012) Aberrant microRNA expression in human cervical carcinomas. Med Oncol 29:1242-1248.
38. Dijkstra JR, van Kempen LC, Nagtegaal ID, Bustin SA (2014) Critical appraisal of quantitative PCR results in colorectal cancer research: Can we rely on published qPCR results? Mol Oncol 8:813-818.
39. Pettengill EA, Parmentier-Line C, Coleman GD (2012) Evaluation of qPCR reference genes in two genotypes of Populus for use in photoperiod and lowtemperature studies. BMC Res Notes 5:366.
40. Kozera B, Rapacz M (2013) Reference genes in real-time PCR. J Appl Genet, 54:391-406
41. Lyng MB, Lænkholm AV, Søkilde R, Gravgaard KH, Litman T, et al. (2012) Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study. PLoS One 7:e36170.
42. Ma MZ, Kong X, Weng MZ, Cheng K, Gong W, et al. (2013) Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance. J Exp Clin Cancer Res 32:71.
43. Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, et al. (2002) Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. 309:293-300.
44. Kheirelseid EA, Chang KH, Newell J, Kerin MJ, Miller N (2010) Identification of endogenous control genes for normalization of real-time quantitative PCR data in colorectal cancer. BMC Mol Biol 11:12.
45. Hu Y, Liu Y, Liu CB, Ling ZQ (2011) Identification of high-risk human papillomavirus (hrHPV)-associated genes in early stage cervical squamous cell carcinomas. J Int Med Res 39:712-728.
46. Shen Y, Wang P, Li Y, Ye F, Wang F, et al. (2013) miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer. Br J Cancer 109:92-9.
47. Yao T, Lin Z (2012) MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Biochim Biophys Acta 822:248-260.
48. Wang F, Li Y, Zhou J, Xu J, Peng C, et al. (2011) miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 179:2580-2588.
49. Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY, et al. (2011) Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein. Eur J Cancer 47:2166-74.
50. Yu J, Wang Y, Dong R, Huang X, Ding S, et al. (2012) Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. J Cancer Res Clin Oncol 138:671-674.
51. Xiao S, Liao S, Zhou Y, Jiang B, Li Y, et al. (2014) High expression of octamer transcription factor 1 in cervical cancer. Oncol Lett 7:1889-1894.
52. Bustin SA, Benes V, Garson J, Hellemans J, Huggett J, et al. (2013) The need for transparency and good practices in the qPCR literature. Nat Methods 10:1063-1067.